This report provides a comprehensive analysis of the global animal-based gelatin haemostatic sponge market, projecting steady growth through 2032. It examines sterile, bioresorbable products derived from porcine or bovine collagen used across surgical and dental applications. The study evaluates market dynamics by type, product form, and end-user, including hospitals and clinics, while profiling key industry players like Johnson & Johnson and B. Braun. Furthermore, the research explores regional trends and strategic developments to identify emerging opportunities within this expanding medical sector.

Market Overview

Global Market Projections

The global Animal-base Gelatin Haemostatic Sponge market size is predicted to grow from US$ 1125 million in 2025 to US$ 1482 million in 2032, representing a compound annual growth rate (CAGR) of 4.4% from 2026 to 2032.

Regional Market Projections

• United States: The market is estimated to experience growth from 2025 through 2032.
• China: The market is estimated to experience growth from 2025 through 2032.
• Europe: The market is estimated to experience growth from 2025 through 2032.

Product Description & Technical Characteristics

Definition and Composition

Animal-based gelatin haemostatic sponge is a sterile, absorbable topical haemostat manufactured from purified gelatin derived from animal collagen sources, most commonly porcine or bovine. The material is processed into a porous sponge matrix that can be cut or shaped and applied directly to a bleeding surface during surgery or dental procedures.

Mechanism of Action

When placed on a wound, the sponge performs the following functions:

• Absorption: Rapidly absorbs blood and exudate.
• Swelling: Expands upon contact with fluids.
• Scaffolding: Provides a mechanical scaffold that supports platelet adhesion and clot formation.
• Synergy: Can be used in conjunction with topical thrombin to accelerate haemostasis in cases of oozing or diffuse bleeding.

Bioresorbability and Clinical Considerations

• Degradation: Because the sponge is bioresorbable, it is designed to be left in situ when removal is impractical, where it will gradually degrade and be absorbed by the body over time, depending on product design and local conditions.
• Safe Use Factors: Selection and safe application depend on the surgical site, available space (noting that swelling can create pressure in confined areas), required size and thickness, and strict compliance with sterility and biocompatibility requirements.

Market Economics

Pricing Structure

Prices for Animal-base Gelatin Haemostatic Sponges vary widely based on brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail).

• Small Dental Cubes: Typically priced around $0.5–$2.0 per piece.
• Standard OR Sheets/Blocks: Commonly priced between $20–$40 per piece.
• Premium Formats: Larger formats or premium branded packs can reach $80–$120 per piece.

Profitability

• Gross Profit Margin: Major companies in the industry maintain gross profit margins between 10% – 30%.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Animal-base Gelatin Haemostatic Sponge Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Animal-base Gelatin Haemostatic Sponge by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Animal-base Gelatin Haemostatic Sponge by Country/Region, 2021, 2025 & 2032

  • 2.2 Animal-base Gelatin Haemostatic Sponge Segment by Type

    • 2.2.1 Porcine Gelatin Haemostatic Sponge

    • 2.2.2 Cow Gelatin Haemostatic Sponge

    • 2.2.3 Others

    • 2.2.4 Animal-base Gelatin Haemostatic Sponge Sales by Type

      • 2.2.4.1 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Animal-base Gelatin Haemostatic Sponge Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Animal-base Gelatin Haemostatic Sponge Sale Price by Type (2021-2026)

  • 2.3 Animal-base Gelatin Haemostatic Sponge Segment by Product Form

    • 2.3.1 Sponge Sheets

    • 2.3.2 Sponge Particles

    • 2.3.3 Others

    • 2.3.4 Animal-base Gelatin Haemostatic Sponge Sales by Product Form

      • 2.3.4.1 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Product Form (2021-2026)
      • 2.3.4.2 Global Animal-base Gelatin Haemostatic Sponge Revenue and Market Share by Product Form (2021-2026)
      • 2.3.4.3 Global Animal-base Gelatin Haemostatic Sponge Sale Price by Product Form (2021-2026)

  • 2.4 Animal-base Gelatin Haemostatic Sponge Segment by Application

    • 2.4.1 Hospitals

    • 2.4.2 Clinics

    • 2.4.3 Others

    • 2.4.4 Animal-base Gelatin Haemostatic Sponge Sales by Application

      • 2.4.4.1 Global Animal-base Gelatin Haemostatic Sponge Sale Market Share by Application (2021-2026)
      • 2.4.4.2 Global Animal-base Gelatin Haemostatic Sponge Revenue and Market Share by Application (2021-2026)
      • 2.4.4.3 Global Animal-base Gelatin Haemostatic Sponge Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Animal-base Gelatin Haemostatic Sponge Breakdown Data by Company

    • 3.1.1 Global Animal-base Gelatin Haemostatic Sponge Annual Sales by Company (2021-2026)

    • 3.1.2 Global Animal-base Gelatin Haemostatic Sponge Sales Market Share by Company (2021-2026)

  • 3.2 Global Animal-base Gelatin Haemostatic Sponge Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Animal-base Gelatin Haemostatic Sponge Revenue by Company (2021-2026)

    • 3.2.2 Global Animal-base Gelatin Haemostatic Sponge Revenue Market Share by Company (2021-2026)

  • 3.3 Global Animal-base Gelatin Haemostatic Sponge Sale Price by Company

  • 3.4 Key Manufacturers Animal-base Gelatin Haemostatic Sponge Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Animal-base Gelatin Haemostatic Sponge Product Location Distribution

    • 3.4.2 Players Animal-base Gelatin Haemostatic Sponge Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Animal-base Gelatin Haemostatic Sponge by Geographic Region

  • 4.1 World Historic Animal-base Gelatin Haemostatic Sponge Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Animal-base Gelatin Haemostatic Sponge Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Animal-base Gelatin Haemostatic Sponge Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Animal-base Gelatin Haemostatic Sponge Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Animal-base Gelatin Haemostatic Sponge Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Animal-base Gelatin Haemostatic Sponge Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Animal-base Gelatin Haemostatic Sponge Sales Growth

  • 4.4 APAC Animal-base Gelatin Haemostatic Sponge Sales Growth

  • 4.5 Europe Animal-base Gelatin Haemostatic Sponge Sales Growth

  • 4.6 Middle East & Africa Animal-base Gelatin Haemostatic Sponge Sales Growth

• 5 Americas

  • 5.1 Americas Animal-base Gelatin Haemostatic Sponge Sales by Country

    • 5.1.1 Americas Animal-base Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 5.1.2 Americas Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 5.2 Americas Animal-base Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 5.3 Americas Animal-base Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Animal-base Gelatin Haemostatic Sponge Sales by Region

    • 6.1.1 APAC Animal-base Gelatin Haemostatic Sponge Sales by Region (2021-2026)

    • 6.1.2 APAC Animal-base Gelatin Haemostatic Sponge Revenue by Region (2021-2026)

  • 6.2 APAC Animal-base Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 6.3 APAC Animal-base Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Animal-base Gelatin Haemostatic Sponge by Country

    • 7.1.1 Europe Animal-base Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 7.1.2 Europe Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 7.2 Europe Animal-base Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 7.3 Europe Animal-base Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Animal-base Gelatin Haemostatic Sponge by Country

    • 8.1.1 Middle East & Africa Animal-base Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Animal-base Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Animal-base Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Animal-base Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Animal-base Gelatin Haemostatic Sponge

  • 10.3 Manufacturing Process Analysis of Animal-base Gelatin Haemostatic Sponge

  • 10.4 Industry Chain Structure of Animal-base Gelatin Haemostatic Sponge

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Animal-base Gelatin Haemostatic Sponge Distributors

  • 11.3 Animal-base Gelatin Haemostatic Sponge Customer

• 12 World Forecast Review for Animal-base Gelatin Haemostatic Sponge by Geographic Region

  • 12.1 Global Animal-base Gelatin Haemostatic Sponge Market Size Forecast by Region

    • 12.1.1 Global Animal-base Gelatin Haemostatic Sponge Forecast by Region (2027-2032)

    • 12.1.2 Global Animal-base Gelatin Haemostatic Sponge Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Animal-base Gelatin Haemostatic Sponge Forecast by Type (2027-2032)

  • 12.7 Global Animal-base Gelatin Haemostatic Sponge Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Pfizer

    • 13.1.1 Pfizer Company Information

    • 13.1.2 Pfizer Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.1.3 Pfizer Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Pfizer Main Business Overview

    • 13.1.5 Pfizer Latest Developments

  • 13.2 Johnson & Johnson

    • 13.2.1 Johnson & Johnson Company Information

    • 13.2.2 Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.2.3 Johnson & Johnson Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Johnson & Johnson Main Business Overview

    • 13.2.5 Johnson & Johnson Latest Developments

  • 13.3 B. Braun

    • 13.3.1 B. Braun Company Information

    • 13.3.2 B. Braun Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.3.3 B. Braun Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 B. Braun Main Business Overview

    • 13.3.5 B. Braun Latest Developments

  • 13.4 Gelita Medical

    • 13.4.1 Gelita Medical Company Information

    • 13.4.2 Gelita Medical Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.4.3 Gelita Medical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Gelita Medical Main Business Overview

    • 13.4.5 Gelita Medical Latest Developments

  • 13.5 Cura Medical

    • 13.5.1 Cura Medical Company Information

    • 13.5.2 Cura Medical Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.5.3 Cura Medical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Cura Medical Main Business Overview

    • 13.5.5 Cura Medical Latest Developments

  • 13.6 Aegis Lifesciences

    • 13.6.1 Aegis Lifesciences Company Information

    • 13.6.2 Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.6.3 Aegis Lifesciences Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Aegis Lifesciences Main Business Overview

    • 13.6.5 Aegis Lifesciences Latest Developments

  • 13.7 COLTENE

    • 13.7.1 COLTENE Company Information

    • 13.7.2 COLTENE Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.7.3 COLTENE Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 COLTENE Main Business Overview

    • 13.7.5 COLTENE Latest Developments

  • 13.8 Dispotech

    • 13.8.1 Dispotech Company Information

    • 13.8.2 Dispotech Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.8.3 Dispotech Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Dispotech Main Business Overview

    • 13.8.5 Dispotech Latest Developments

  • 13.9 Ferrosan Medical Devices

    • 13.9.1 Ferrosan Medical Devices Company Information

    • 13.9.2 Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.9.3 Ferrosan Medical Devices Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Ferrosan Medical Devices Main Business Overview

    • 13.9.5 Ferrosan Medical Devices Latest Developments

  • 13.10 EUCARE Pharmaceuticals

    • 13.10.1 EUCARE Pharmaceuticals Company Information

    • 13.10.2 EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.10.3 EUCARE Pharmaceuticals Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 EUCARE Pharmaceuticals Main Business Overview

    • 13.10.5 EUCARE Pharmaceuticals Latest Developments

  • 13.11 BOENMED

    • 13.11.1 BOENMED Company Information

    • 13.11.2 BOENMED Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.11.3 BOENMED Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 BOENMED Main Business Overview

    • 13.11.5 BOENMED Latest Developments

  • 13.12 Medelast

    • 13.12.1 Medelast Company Information

    • 13.12.2 Medelast Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.12.3 Medelast Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Medelast Main Business Overview

    • 13.12.5 Medelast Latest Developments

  • 13.13 JIAXING KENYUE

    • 13.13.1 JIAXING KENYUE Company Information

    • 13.13.2 JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.13.3 JIAXING KENYUE Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 JIAXING KENYUE Main Business Overview

    • 13.13.5 JIAXING KENYUE Latest Developments

  • 13.14 Medzeel Lifescience

    • 13.14.1 Medzeel Lifescience Company Information

    • 13.14.2 Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.14.3 Medzeel Lifescience Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Medzeel Lifescience Main Business Overview

    • 13.14.5 Medzeel Lifescience Latest Developments

  • 13.15 Goodwill Lifesciences

    • 13.15.1 Goodwill Lifesciences Company Information

    • 13.15.2 Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.15.3 Goodwill Lifesciences Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Goodwill Lifesciences Main Business Overview

    • 13.15.5 Goodwill Lifesciences Latest Developments

  • 13.16 Equimedical

    • 13.16.1 Equimedical Company Information

    • 13.16.2 Equimedical Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.16.3 Equimedical Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Equimedical Main Business Overview

    • 13.16.5 Equimedical Latest Developments

  • 13.17 Healthium Medtech

    • 13.17.1 Healthium Medtech Company Information

    • 13.17.2 Healthium Medtech Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.17.3 Healthium Medtech Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Healthium Medtech Main Business Overview

    • 13.17.5 Healthium Medtech Latest Developments

  • 13.18 Septodont

    • 13.18.1 Septodont Company Information

    • 13.18.2 Septodont Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.18.3 Septodont Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Septodont Main Business Overview

    • 13.18.5 Septodont Latest Developments

  • 13.19 Assut Europe

    • 13.19.1 Assut Europe Company Information

    • 13.19.2 Assut Europe Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.19.3 Assut Europe Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 Assut Europe Main Business Overview

    • 13.19.5 Assut Europe Latest Developments

  • 13.20 Nanchang Hushida Medical Technology

    • 13.20.1 Nanchang Hushida Medical Technology Company Information

    • 13.20.2 Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.20.3 Nanchang Hushida Medical Technology Animal-base Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 Nanchang Hushida Medical Technology Main Business Overview

    • 13.20.5 Nanchang Hushida Medical Technology Latest Developments

• 14 Research Findings and Conclusion